Workflow
Wellgistics Health Inc(WGRX) - 2025 Q2 - Quarterly Results

FORM 8-K General Information This section provides essential identification details for WELLGISTICS HEALTH, INC. and its registered securities Registrant Information This section identifies WELLGISTICS HEALTH, INC. as the registrant, detailing its state of incorporation, principal executive offices, and contact number, and confirms its emerging growth company status - Registrant Name: WELLGISTICS HEALTH, INC.2 - State of Incorporation: Delaware2 - Principal Executive Offices: 3000 Bayport Drive, Suite 950, Tampa, FL 336072 - Registrant's Telephone Number: (844) 203-60922 - Emerging Growth Company Status: Yes (☒)4 Securities Information This part specifies the securities registered under Section 12(b) of the Act, identifying the class of stock, its trading symbol, and the exchange of registration Securities Registered | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | :--- | :--- | :--- | | Common Stock, par value $0.0001 per share | WGRX | The Nasdaq Stock Market LLC | Item 2.02 Results of Operations and Financial Condition This item incorporates the company's financial results by reference, clarifying their legal status under securities regulations Summary of Results of Operations and Financial Condition This item incorporates by reference financial results disclosed under Item 7.01, clarifying that the furnished information is not considered 'filed' for Section 18 purposes nor incorporated by reference into other filings unless expressly stated - Information from Item 7.01 is incorporated by reference into this Item 2.025 - The furnished information, including the referenced exhibit, is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 19346 - The information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth6 Item 7.01 Regulation FD Disclosure This section details the public disclosure of WELLGISTICS HEALTH, INC.'s financial results for the second fiscal quarter Summary of Regulation FD Disclosure WELLGISTICS HEALTH, INC. announced its financial results for the second fiscal quarter ended June 30, 2025, via a press release issued on August 20, 2025, which is filed as Exhibit 99.1 but not considered 'filed' for Section 18 liabilities - A press release announcing financial results for the second fiscal quarter ended June 30, 2025, was issued on August 20, 20257 - The press release is filed as Exhibit 99.1 and incorporated by reference7 - The press release (Exhibit 99.1) is not deemed 'filed' for Section 18 purposes of the Securities Exchange Act of 19348 Item 9.01 Financial Statements and Exhibits This item lists the official exhibits accompanying the Form 8-K filing, including the financial results press release Summary of Financial Statements and Exhibits This section lists the exhibits included with the Form 8-K filing, specifically Exhibit 99.1, the press release detailing financial results, and Exhibit 104, the Cover Page Interactive Data File Exhibits Included | Exhibit Number | Description | | :--- | :--- | | 99.1 | Press Release by Wellgistics Health, Inc., dated August 20, 2025 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | Signatures This section formally attests to the authenticity and authorization of the Form 8-K filing by the company's Chief Financial Officer Summary of Signatures This section confirms the official signing of the Form 8-K report by an authorized officer of Wellgistics Health, Inc., ensuring compliance with Securities Exchange Act of 1934 requirements - The report was signed on behalf of Wellgistics Health, Inc. by Mark DiSiena, Chief Financial Officer1314 - The report is dated August 22, 202514